Intrinsic Value of S&P & Nasdaq Contact Us

Kezar Life Sciences, Inc. KZR NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
33/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$6.00
-18.5%

Stock Statistics — KZR

Kezar Life Sciences, Inc. (KZR) has a market capitalization of $54.25M and trades at $7.36. The 52-week range is 3.53-7.55.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1, Earnings Per Share (EPS) of $-7.66.

The stock has a beta of 0.43, operates in the Healthcare sector.

Trading Data
Current Price$7.36
52-Week Range3.53-7.55
Volume451.8K
Avg Volume (30D)60.27K
Market Cap$54.25M
Beta (1Y)0.43
Company
IPO Date2018-06-21
Employees55
CEOChristopher J. Kirk
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS49372L2097
CUSIP49372L100
Income (Latest Year)
Gross Profit$-897K
EBITDA$-51.37M
Operating Income$-52.27M
Net Income$-56.03M
EPS$-7.66
EPS Diluted$-7.66
Shares Outstanding$7.32M
Balance Sheet (Latest Year)
Total Assets$76.65M
Current Assets$75.73M
Cash & ST Investments$71.88M
Total Liabilities$6.57M
Total Debt$2.33M
Net Debt$-69.55M
Total Equity$70.07M
Debt / Equity0.03
Valuation Ratios
P/E Ratio-1
P/B Ratio0.77
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message